Skip to content

What is the controversy with the RXBars? A deep dive into lawsuits and recalls

4 min read

In June 2018, a class-action lawsuit was filed against RXBar's parent company, sparking a major part of the controversy with the RXBars over misleading ingredient representations. This initial legal action, combined with subsequent safety issues, significantly challenged the brand’s hard-won reputation for simple, transparent ingredients.

Quick Summary

The controversy surrounding RXBars stems from a 2018 class-action lawsuit over misleading "clean label" claims and extensive product recalls in 2019 due to undeclared peanut allergens. This created a profound conflict with the brand's minimalist, transparent marketing, leading to damaged consumer trust and intense public scrutiny.

Key Points

  • Misleading Ingredient Claims: RXBar was sued in 2018 for allegedly mislabeling ingredients like "egg whites" (actually protein powder) and "real fruit" (actually concentrate).

  • Contradiction to 'No B.S.' Motto: The legal action created a stark contrast with the brand's core identity of simple, transparent, and honest ingredients.

  • Widespread Peanut Recalls: In late 2018 and early 2019, RXBar issued multiple recalls due to undeclared peanut allergens from a third-party supplier, posing a serious risk to consumers with allergies.

  • Damaged Consumer Trust: The combination of misleading labeling and product safety failures severely compromised the public's trust in the brand's integrity and quality control.

  • Increased Scrutiny on 'Clean Labels': The RXBar controversies intensified the focus on transparency within the food industry and the potential pitfalls of marketing minimalist, "clean label" products.

In This Article

The 'Clean Label' Promise and Legal Backlash

RXBar built its initial success on a seemingly simple and honest promise: listing a handful of whole food ingredients plainly on the front of its wrapper, along with its "No B.S." motto. This resonated with health-conscious consumers seeking transparency in an often-confusing market. However, this positioning became the very source of its undoing when it faced legal challenges in 2018.

The 2018 Class-Action Lawsuit

In June 2018, a class-action lawsuit was filed against the Chicago Bar Company, the maker of RXBar, alleging the brand misled consumers about its ingredients. The complaint highlighted two primary issues:

  • Egg Whites vs. Egg White Powder: While the packaging simply stated "egg whites," the company allegedly used processed egg white protein powder. The lawsuit claimed consumers would be less likely to purchase a product marketed as 'natural' and 'wholesome' if they knew it contained a protein powder.
  • Real Fruit vs. Fruit Concentrate: Similarly, claims of using "real fruit" were contradicted by the use of fruit that was "infused" or flavored with sweetening agents like apple juice concentrate. This, according to the lawsuit, was a deliberate omission aimed at making the product appear healthier and more natural than it was.

The legal action created significant media attention and put the brand's integrity under the microscope. Critics argued that the company was capitalizing on the clean-label trend while failing to be completely transparent with its customers, a direct contradiction to its prominent marketing message.

The Extensive Peanut Allergen Recalls

Adding to its legal troubles, RXBar faced a major food safety crisis in late 2018 and early 2019, leading to an expanded recall of numerous products due to undeclared peanuts.

A Problematic Third-Party Supplier

The recall began in December 2018 with two flavors, Chocolate Sea Salt and Coconut Chocolate, after the company identified a potential for peanut cross-contamination. The investigation traced the issue to a specific ingredient supplied by a third party. Despite the problem originating with a supplier, the responsibility fell on RXBar, and the incident severely damaged consumer trust, especially among those with serious allergies.

Expanding the Scope

After initial reports of allergic reactions from consumers, the company expanded the recall in January 2019 to include over a dozen flavors, both in its regular and kids' lines. This second, broader recall indicated the cross-contamination issue was more widespread than initially thought, magnifying the brand's crisis. While the company moved quickly to change suppliers and address the issue, the damage to its reputation was already done. The irony of a health-focused, transparent brand failing on a fundamental food safety issue was not lost on consumers.

Brand Image versus Reality: A Comparison

Aspect Pre-Controversy Perception Post-Controversy Reality
Ingredients Simple, whole, and completely natural foods as listed on the wrapper. Highly processed components, including egg white protein powder and juice concentrate, used to create the final product.
Transparency The brand was a leader in transparent, "No B.S." marketing, building trust with consumers. The brand was accused of misleading consumers, deliberately omitting key information to appeal to the "clean label" trend.
Safety High standard of safety and quality control, especially for a premium product. Revealed vulnerability in the supply chain, leading to a widespread recall of products contaminated with undeclared allergens.
Brand Value A disruptive, authentic, and fast-growing startup, attractive to consumers and large corporations. Seen as a brand whose core promises were compromised, leading to a loss of trust and intense public scrutiny.

Key Moments in the RXBar Controversy

  • October 2017: Kellogg's acquires RXBar for $600 million, a move that would later be scrutinized in the context of subsequent issues.
  • June 2018: A class-action lawsuit is filed, challenging the brand's ingredient labeling related to egg white protein powder and fruit concentrate.
  • December 2018: RXBar announces a voluntary recall of two flavors due to potential undeclared peanuts, citing a third-party ingredient supplier issue.
  • January 2019: The company expands its recall to include a wider variety of bars after receiving consumer reports of allergic reactions.
  • December 2020: Kellogg's closes RXBar's UK operation, signaling challenges for the brand outside its core US market.

Conclusion: The Lingering Aftermath

The controversy with the RXBars serves as a powerful case study in the food industry, illustrating the significant risks of branding based on radical transparency. For a brand that literally printed its simple ingredients on the front of every package, the revelation of misleading practices and serious allergen safety failures was a devastating blow. While the company acted to correct the issues, the incident highlighted the critical importance of a robust supply chain and the profound impact of consumer trust. The RXBar saga demonstrates that today's discerning consumer expects brands to not only be transparent but also to live up to their promises in every aspect of their business. The brand's journey from a startup darling to a company embroiled in controversy underscores how quickly public perception can shift when integrity is questioned.

For more details on the 2018 lawsuit and its context, you can review the coverage by Truth in Advertising, Inc..

Frequently Asked Questions

The RXBar lawsuit, filed in 2018, centered on allegations that the company's ingredient labeling was misleading. Specifically, the suit claimed that the brand used egg white protein powder instead of whole egg whites and fruit concentrate instead of just "real fruit".

RXBars were recalled in 2019 due to the potential presence of an undeclared peanut allergen. The company discovered that an ingredient supplied by a third party was contaminated, leading to a widespread recall to prevent allergic reactions.

The recalls, especially concerning allergens, severely damaged consumer trust. For a brand that built its reputation on transparency and simple ingredients, the food safety failure was a major contradiction to its core message.

Yes, following the ingredient lawsuit and consumer feedback, RXBar later included "natural flavors" in some formulations. This move drew further criticism from consumers who valued the brand's original, hyper-minimalist ingredient list.

The 'No B.S.' motto was a central part of RXBar's branding, promising simple, honest ingredients without unnecessary additives. The controversy, which involved allegations of misleading labeling, was seen as a direct contradiction to this very promise.

The recalls for undeclared peanuts concluded, and the FDA terminated the recall action after the company addressed the supply chain issue. Current RXBars are considered safe for consumption based on the corrected manufacturing process and revised labels.

RXBar was acquired by the Kellogg Company (now Kellanova) in 2017. The acquisition occurred before the lawsuits and recalls, but the parent company oversaw the brand during these controversial periods.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.